Search results
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.
Information on acquisition, funding, investors, and executives for Avanir Pharmaceuticals. Use the PitchBook Platform to explore the full profile.
2 gru 2014 · Avanir Pharmaceuticals, Inc. is a biopharmaceutical company specializing in CNS diseases. Avanir developed and launched NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) 20mg/10mg capsules in the US in February 2011 as the world’s first and only approved treatment for the neurologic disease pseudobulbar affect (PBA).
Study Avanir Pharmaceuticals's history, mission, products/services, target market and competition. Understand how the company operates in its industry and analyse its health with key financial statements including revenue, expenses, assets, liabilities and cash flow.
26 cze 2012 · Phone Number (194) 938-9670. Avanir Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.
7 lis 2014 · Avanir Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries.
Avanir Pharmaceuticals Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | Nasdaq.
